A kind of edaravone drug co-crystal and preparation method thereof
A technology for edaravone and medicine is applied in the field of novel edaravone medicine co-crystal and the preparation field of the medicine co-crystal, and can solve the problems of poor stability of edaravone, decreased content of edaravone raw materials and the like
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Publication Date
- 2015-08-05
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of organic drug co-crystals, and in particular relates to a novel edaravone drug co-crystal and a preparation method of the drug co-crystal. Background technique
[0002] Supramolecular chemistry is a science that studies molecular aggregates that are complex and orderly and have specific structures and functions formed by the association between molecules. Supramolecular chemistry has the following notable features: a. The strong binding force that forms supramolecular compounds is the result of the superposition and synergy of weak interaction forces between different molecules, and is a comprehensive expression of various forces; b. It is formed by the self-assembly of different molecules Supramolecular compounds show new functions that are completely different from the original self-assembled molecules. Its core content is molecular recognition and supramolecular self-assembly through the synergy of wea...
Examples
Embodiment 1
[0053] Accurately weigh 39.9 mg of Edaravone and 260.1 mg of β-cyclodextrin, add 6 ml of a mixed solvent of ethanol and water (volume ratio 1:7), heat to 50-80 °C, and react for 0.5 h under stirring. Stirring was stopped, the temperature was lowered naturally, and after cooling down to room temperature, crystals were precipitated after standing still for 12-24 hours, which was the Edaravone / β-cyclodextrin eutectic.
Embodiment 2
[0055] Accurately weigh 39.9 mg of Edaravone and 260.1 mg of β-cyclodextrin, add 10 ml of a mixed solvent of methanol and water (volume ratio 1:1), heat to 50-65 ° C, and react for 0.5 h under stirring. Stirring was stopped, the temperature was lowered naturally, and after cooling down to room temperature, crystals were precipitated after standing still for 12-24 hours, which was the Edaravone / β-cyclodextrin eutectic.
Embodiment 3
[0057] Accurately weigh 39.9 mg of Edaravone and 260.1 mg of β-cyclodextrin, add 8 ml of a mixed solvent of isopropanol and water (volume ratio 1:5), heat to 50-80 °C, and react for 0.5 h under stirring. Stirring was stopped, the temperature was lowered naturally, and after cooling down to room temperature, crystals were precipitated after standing still for 12-24 hours, which was the Edaravone / β-cyclodextrin eutectic.